FindTrial
Sign In

The effect of remote ischemic preconditioning on serum NSE, S100ß and Ngb in patients in patients with intracranial aneurysm treatment

The effect of remote ischemic preconditioning on serum NSE, S100ß and Ngb in patients in patients with intracranial aneurysm treatment

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800017238
Enrollment
Unknown
Registered
2018-07-19
Start date
2018-08-01
Completion date
Unknown
Last updated
2018-07-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intracranial aneurysm

Interventions

RIPC group:RIPC
Control group:none

Sponsors

Affiliated Hospital of Xuzhou Medical University, Jiangsu Province
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. patients with craniotomy aneurysm clipping; 2. Hunt-Hess grade 0-II; 3. Fisher grade I-II; 4. aged 18-65 years; 5. patients agreed to participate in the trial.

Exclusion criteria

Exclusion criteria: 1. patients with bacterial aneurysms and dissection aneurysms; 2. patients with a history of stroke or TIA within 6 months; 3. patients with obvious symptoms of peripheral vascular disease; 4. patients with systemic diseases affecting relevant indicators; 5. pregnant women; 6. patients with diseases that are not suitable for RIPC treatment, such as cardiac ischemic disease, abnormal blood coagulation, deep vein thrombosis of the lower extremities; 7. autologous blood recovery during surgery.

Design outcomes

Primary

MeasureTime frame
Neuron specific enolase;S-100ß;neuroglobin;—

Countries

China

Contacts

Public ContactXiuxia Chen

Affiliated Hospital of Xuzhou Medical University, Jiangsu Province

cxxlxy@sina.com+86 18052268332/15205200798

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026